Symptom reporting and tracking
depression, sleep disturbance, pain
METASTATIC CANCER
At least one symptom was reported by 43% (46) of participants, and 40% (43) reported multiple symptoms through the app. The most commonly reported symptoms were: GI issues (30%), sleep disturbance (29%), pain (28%), mood issues (18%), and neurologic issues (17%) (Supplementary Materials Table Interestingly, several symptoms were reported more frequently by patients in the app than documented by providers in the EHR. Cognitive issues, sexual health problems (decreased libido), and depression were rare (< 10%), but were reported in the app by at least 5% of participants, and virtually never reported in the EHR (Table Most Commonly Reported Symptoms in App and Electronic Health Record (EHR) among Total Study Population and Population Highly Engaged with App* = Significant difference at the level of Among patients with metastatic cancer, 41% reported that the app helped them track their symptoms. Fifty-five percent of patients on adjuvant or neoadjuvant chemotherapy found the app helpful for symptom tracking, as did 57% of newly diagnosed patients.